Former Head of GSK China Has Been Asked Not to Leave

Mark Reilly, the former head of GlaxoSmithKline in China, is back in China and has been asked not to leave the country. According to GSK, he has been “helping” the police investigate the alleged bribery practices in Changsha. Earlier, China authorities said GSK may have spent up to $489 million on bribing doctors and government officials. More details.... Stock Symbol: (NYSE: GSK) Share this with colleagues: // //